Coexistence of primary aldosteronism and Hashimoto's thyroiditis

Rheumatology International

Volumn 32, Issue 8, 2012, Pages 2561-2563

  Krysiak, Robert ^a   Okopien, Bogusław ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Diagnosis and treatment; Hashimoto's thyroiditis; Primary aldosteronism; Proinflammatory cytokines

Indexed keywords

LEVOTHYROXINE; SPIRONOLACTONE;

ADRENAL TUMOR; ADRENALECTOMY; ADULT; ALDOSTERONE RELEASE; ARTICLE; AUTOIMMUNE DISEASE; CASE REPORT; COMORBIDITY; CYTOKINE RELEASE; DISEASE ASSOCIATION; DISEASE EXACERBATION; DRUG DOSE REDUCTION; FEMALE; HASHIMOTO DISEASE; HUMAN; LAPAROSCOPIC SURGERY; LYMPHOCYTE; MONOCYTE; PRIMARY HYPERALDOSTERONISM; PRIORITY JOURNAL;

ADRENAL CORTEX FUNCTION TESTS; ADRENAL GLAND NEOPLASMS; ADRENALECTOMY; ADULT; ALDOSTERONE; AUTOIMMUNITY; BIOLOGICAL MARKERS; CYTOKINES; FEMALE; HASHIMOTO DISEASE; HUMANS; HYPERALDOSTERONISM; INFLAMMATION MEDIATORS; MINERALOCORTICOID RECEPTOR ANTAGONISTS; THYROID FUNCTION TESTS; THYROID HORMONES; THYROXINE; TREATMENT OUTCOME;

EID: 84866236010     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-011-2032-6     Document Type: Article

References (10)

1. Mulatero P, Monticone S, Bertello C, Tizzani D, Iannaccone A, Crudo V, Veglio F (2010) Evaluation of primary aldosteronism. Curr Opin Endocrinol Diabetes Obes 17:188-193
2. Young W (2007) Primary aldosteronism: renaissance of the syndrome. Clin Endocrinol 66:607-618
3. Yoshimoto T, Hirata Y (2007) Aldosterone as a cardiovascular risk hormone. Endocr J 54:359-370
4. Caturegli P, Kimura H, Rocchi R, Rose NR (2007) Autoimmune thyroid diseases. Curr Opin Rheumatol 19:44-48
5. Lorini R, Gastaldi R, Traggiai C, Perucchin PP (2003) Hashimoto's thyroiditis. Pediatr Endocrinol Rev 1(Suppl 2):205-211
6. Tanaka M, Izeki M, Miyazaki Y, Horigome M, Yoneda T, Tsuyuki S, Takami S, Aiba M (2002) Combined primary aldosteronism and Cushing's syndrome due to a single adrenocortical adenoma complicated by Hashimoto's thyroiditis. Intern Med Nov 41:967-971
7. Okopień B, Krysiak R, Kowalski J, Madej A, Belowski D, Zieliński M, Herman ZS (2005) Monocyte release of tumor necrosis factor-alpha and interleukin-1beta in primary type IIa and IIb dyslipidemic patients treated with statins or fibrates. J Cardiovasc Pharmacol 46:377-386
8. Okopień B, Krysiak R, Kowalski J, Madej A, Belowski D, Zieliński M, Labuzek K, Herman ZS (2004) The effect of statins and fibrates on interferon-gamma and interleukin-2 release in patients with primary type II dyslipidemia. Atherosclerosis 176:327-335
9. Brown RS (2009) Autoimmune thyroid disease: unlocking a complex puzzle. Curr Opin Pediatr 21:523-528
10. Bendtzen K, Hansen PR, Rieneck K, Spironolactone/Arthritis Study Group (2003) Spironolactone inhibits production of proinflammatory cytokines, including tumour necrosis factor-alpha and interferon-gamma, and has potential in the treatment of arthritis. Clin Exp Immunol 134:151-158